Patricia Tarraga-Garcia
Valencia, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Glioblastoma progression is hindered by melatonin-primed mesenchymal stromal cells through dynamic intracellular and extracellular reorganizations.
Journal: Theranostics
Published: September 24, 2024
BCAS1 defines a heterogeneous cell population in diffuse gliomas.
Journal: Oncotarget
Published: January 26, 2024
Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 13, 2023
Glioblastoma disrupts the ependymal wall and extracellular matrix structures of the subventricular zone.
Journal: Fluids and barriers of the CNS
Published: March 11, 2022
Ultrastructural Characterization of Human Oligodendrocytes and Their Progenitor Cells by Pre-embedding Immunogold.
Journal: Frontiers in neuroanatomy
Published: April 16, 2021
Immunogold Labeling to Detect Streptococcus pyogenes Cas9 in Cell Culture and Tissues by Electron Microscopy.
Journal: The CRISPR journal
Published: December 21, 2019
Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: February 19, 2016
The adult macaque spinal cord central canal zone contains proliferative cells and closely resembles the human.
Journal: The Journal of comparative neurology
Published: June 20, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026